Mamaki Polyphenol Composition for Cerebral Function Maintenance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing anti-dementia drugs have failed to demonstrate efficacy in clinical trials, and there is a need for a novel means to maintain or improve cerebral function, promote nerve cell repair, induce neurogenesis, remove neurodegenerative disease-causing proteins, or treat/prevent neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Lewy body dementia.
Innovation Solution
An herbal medicine derived from mamaki leaves, fruit, and seeds, containing polyphenols like catechin, chlorogenic acid, and rutin, is used to improve cerebral function, promote nerve cell repair, induce neurogenesis, and remove neurodegenerative disease-causing proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-dementia drugs are used to suppress production or remove neurodegenerative proteins, then the intended therapeutic effect is achieved, but clinical trials have failed to demonstrate expected efficacy
Solution Approach 1:
The patent changes the chemical parameters by using natural polyphenolic compounds (catechin, chlorogenic acid, rutin) from mamaki instead of conventional synthetic anti-dementia drugs. These compounds have different molecular structures and mechanisms of action that can simultaneously address multiple pathological features including protein aggregation and neuroinflammation, thereby improving therapeutic efficacy where conventional drugs have failed
Solution Approach 2:
The patent employs a composite approach by using multiple polyphenolic compounds from mamaki that work synergistically. The combination of catechin, chlorogenic acid, and rutin provides multifaceted therapeutic effects including antioxidant activity, anti-inflammatory effects, and inhibition of protein aggregation, creating a more effective treatment than single compounds
2Quantity of substance
If proteins such as Aβ and tau are suppressed or removed from the brain, then neurodegenerative disease pathology is reduced, but nerve cell death and dementia progression continue
Solution Approach 1:
The patent converts the harmful accumulated proteins into beneficial therapeutic targets by using polyphenolic compounds that bind to and stabilize these proteins, preventing their toxic aggregation while promoting their clearance. The compounds transform the pathological protein accumulation process into a controlled mechanism that reduces toxicity and promotes neuroprotection
Solution Approach 2:
The polyphenolic compounds from mamaki act as intermediary molecules that mediate between the accumulated neurodegenerative proteins and the nervous system. These compounds bind to proteins like Aβ and tau, modulating their aggregation properties and facilitating their removal while simultaneously providing neuroprotective effects to prevent nerve cell death
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3B
AI summary
A brain function maintenance or improvement agent is provided that contains herbal medicine selected from mamaki leaves, fruit, and seeds.